Ir.opthea.com

  1. Home
  2. Ir.opthea.com

Investor Relations

WEBOpthea is committed to improving vision in patients suffering from retinal eye diseases. We are developing a novel therapeutic called OPT-302, a VEGF-C/D ‘trap’, to …

Actived: 2 days ago

URL: https://ir.opthea.com/

Opthea Expands Global Phase 3 ShORe and COAST Wet AMD …

WEBMELBOURNE, Australia, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel …

Category:  Health Go Health

Opthea Strengthens Team with Key Clinical and Regulatory Hires

WEBOpthea Limited (ASX:OPT; NASDAQ:OPT, “Opthea”) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of …

Category:  Health Go Health

Opthea Presentation at The Retina World Congress 2022

WEBMELBOURNE, Australia, May 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing …

Category:  Health Go Health

Opthea Announces “Sozinibercept” as the Nonproprietary Drug …

WEBOpthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302. July 26, 2023 at 6:00 AM EDT. Download PDF. MELBOURNE, Australia, July …

Category:  Health Go Health

Beyond VEGF-A: Targeting VEGF-C/D for Wet AMD and DME

WEB3 Wet AMD & DME are the leading causes of vision loss in the elderly & diabetics Increasing prevalence; large unmet medical need Source: GlobalData; EvaluatePharma; …

Category:  Medical Go Health

Opthea to Present at the Jefferies 2023 London Healthcare …

WEBMELBOURNE, Australia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing …

Category:  Health Go Health

Opthea Presentation at The Retina World Congress 2022

WEBOpthea Presentation at The Retina World Congress 2022 May 10, 2022 MELBOURNE, Australia, May 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; …

Category:  Health Go Health

Opthea Presentation at The Retina World Congress 2022

WEBASX, Nasdaq and Media Release 10 May 2022 Opthea Presentation at The Retina World Congress 2022 Melbourne, Australia; 10 May, 2022 – Opthea Limited (ASX:OPT; …

Category:  Health Go Health

Opthea Appoints Anshul Thakral as Non-Executive Director of the …

WEBMELBOURNE, Australia, June 08, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing …

Category:  Health Go Health

Leading Therapeutic Innovation in Retinal Diseases

WEBDisclaimer This presentation includes general background information about the activities of Opthea Limited (ABN 32 006 340 567) (‘Opthea’ or ‘Company’) and its affiliates and

Category:  Health Go Health

OPT-302 for wetAMD

WEB3 First and only retina asset with strong clinical evidence of better visual outcomes over anti-VEGF-A therapy for wet AMD, with well tolerated safety profile Currently available …

Category:  Health Go Health

Leading Therapeutic Innovation in Retinal Diseases

WEBDisclaimer. This presentation includes general background information about the activities of Opthea Limited (ABN 32 006 340 567) (‘ Opthea’ or ‘Company’) and its affiliates and …

Category:  Health Go Health

Transforming Patient Outcomes with Superior Vision Gains

WEBPolypoidal Choroidal Vasculopathy (. PCV. ) is a difficult-to-treat wet AMD subtype; it is often described as the. most prevalent form of wet AMD worldwide. PCV is. highly …

Category:  Health Go Health

2018 Annual General Meeting

WEB2018 Annual General Meeting CEO Presentation –2018 AGM, November 29 2018 Megan Baldwin PhD, CEO & Managing Director

Category:  Health Go Health

Leading Therapeutic Innovation in Retinal Diseases

WEBWet AMD & DME Are the Leading Causes of Vision Loss in the Elderly and Diabetics Increasing prevalence; large & growing market opportunity *United States and Europe; …

Category:  Health Go Health

Opthea Reports Fiscal Year 2022 Financial Results and Corporate

WEBAustralia: U.S.A. & International: Rudi Michelson, Monsoon Communications Tel: +61 (0) 3 9620 3333 Sam Martin, Argot Partners Tel: +1 212-600-1902

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Public health childhood obesity

 › Health innovation network uk

 › Pottstown tower health pay bill

 › Brain health on heart health

 › Fitchburg state university health requirements

 › Christian ministries health insurance login

 › Atrius health primary care jobs

 › Foods that are good for your brain health

 › What is good for brain health

 › Healthy heart and brain

Recently Searched

 › Physical activity for brain health

 › Hca health care accounts payable

 › Ohio health police department

 › Mersey care netherton health centre

 › Seiu healthcare provider portal

 › Cleveland health department phone number

 › Wps health solutions phone number

 › Frimley health maternity guidelines

 › Health services financing commerce bank

 › Mcgill healthcare management courses